Collaborative Breakthrough in Lung-on-Chip Technology: AlveoliX, VITROCELL, University of Bern and Helmholtz Institute for Pharmaceutical Research Saarland Drive Advances in Human Respiratory Research
AlveoliX, in collaboration with VITROCELL Systems, the University of Bern, and the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) is proud to announce the publication of a landmark study in Bioengineering & Translational Medicine. The study, titled “A stretchable human lung-on-chip model of alveolar inflammation for evaluating anti-inflammatory drug response”, was made possible through the AIM-4-Doc grant from Eurostars.
This study demonstrates how this Lung-on-Chip model provides an advanced platform to study human lung function, offering a more accurate and predictive approach to investigating respiratory diseases and testing potential treatments.
Read the full version: Press-Release.pdf
Read the publication: A stretchable human lung-on-chip model of alveolar inflammation for evaluating anti-inflammatory drug response
